Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874286 · ClinicalTrials.gov registry record
The TOGETHER Project - Liver
A clinical trial of Liver Transplant Rejection, sponsored by Mayo Clinic.
- Completed
- Registry status
- 54
- Enrollment target
- 3
- Study locations
NCT03874286 is a study of Liver Transplant Rejection that has completed, run by Mayo Clinic. The registered enrollment target is 54 participants, above the 37-participant average among 3 other Liver Transplant Rejection trials with a reported enrollment target (46% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT03874286, a study of Liver Transplant Rejection, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 3
- Study locations
Study Summary
To validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Liver Transplant
Study Locations (3)
Arizona
- Mayo Clinic - Phoenix
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-03-15 |
| Est. Completion | 2020-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03874286
The ClinicalTrials.gov registry entry for NCT03874286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 37-participant average among 3 other Liver Transplant Rejection trials with a reported enrollment target (46% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplant Rejection appearing as the primary indexed condition, and to 1 intervention - of which Liver Transplant is the first listed.
NCT03874286 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03874286 about?
NCT03874286 is a clinical study titled "The TOGETHER Project - Liver". To validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results.
What is the current status of trial NCT03874286?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-03-15. Estimated completion is 2020-04-30.
What conditions does trial NCT03874286 study?
This clinical trial studies the following conditions: Liver Transplant Rejection.
What interventions are being tested in trial NCT03874286?
The interventions under investigation include: Liver Transplant (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03874286?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03874286 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant Rejection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
ACTIVE NOT RECRUITING · Phase 4
-
Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients
ACTIVE NOT RECRUITING
-
Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.